Contract facts
UnrestrictedNo full NAICS 325412 intel page yet. Browse NAICS intelligence
VACCINES INCLUDING BUT NOT LIMITED TO: HEPATITIS A, HEPATITIS B, COMBINED HEPATITIS A AND B, MMR MEASLES, MUMPS, RUBELLA, TD TETANUS, DIPHTHERIA, TDAP TETANUS, DIPHTHERIA AND PERTUSSIS, MENINGITIS, RABIES, POLIO, TYPHOID INJECTABLE AND ORAL, YELLOW is a federal Unrestricted award for Division 1200 held by Sanofi Pasteur Inc. Estimated value $625K ($542K obligated). Current period of performance ends Feb 26, 2025. Last award drew 1 bidder. Place of performance: SWIFTWATER PA.
VACCINES INCLUDING BUT NOT LIMITED TO: HEPATITIS A, HEPATITIS B, COMBINED HEPATITIS A AND B, MMR MEASLES, MUMPS, RUBELLA, TD TETANUS, DIPHTHERIA, TDAP TETANUS, DIPHTHERIA AND PERTUSSIS, MENINGITIS, RABIES, POLIO, TYPHOID INJECTABLE AND ORAL, YELLOW
Recompete timing
PublicCurrent PoP ended Feb 26, 2025 (582 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 15F06722F0000478? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordSanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 15F06722F0000478?
15F06722F0000478 (Vaccines including BUT NOT limited to) is a Division 1200 award with a potential value of $625K, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 15F06722F0000478?
Division 1200 awarded 15F06722F0000478 to Sanofi Pasteur Inc (potential $625K).
Who is the incumbent on 15F06722F0000478?
Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Feb 26, 2025.
When does Sanofi Pasteur Inc’s 15F06722F0000478 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 26, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 15F06722F0000478? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.